EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hologic's enterprise value is $18,338 Mil.
Hologic's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,063 Mil. Therefore, Hologic's EV-to-EBITDA for today is 17.25.
The historical rank and industry rank for Hologic's EV-to-EBITDA or its related term are showing as below:
HOLX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.39 Med: 14.14 Max: 75.71
Current: 17.25
During the past 13 years, the highest EV-to-EBITDA of Hologic was 75.71. The lowest was -32.39. And the median was 14.14.
HOLX's EV-to-EBITDA is ranked worse than 57.08% of 487
companies
in the Medical Devices & Instruments industry
Industry Median: 14.42
vs HOLX: 17.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-20), Hologic's stock price is $75.371.
Hologic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.110. Therefore, Hologic's PE Ratio for today is 35.72.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Hologic EV-to-EBITDA Historical Data
The historical data trend for Hologic's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hologic Annual Data
Trend
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Sep22
Sep23
EV-to-EBITDA
46.28
13.09
7.23
7.82
15.27
Hologic Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBITDA
11.02
14.42
17.53
15.27
16.37
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Hologic's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic EV-to-EBITDA Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hologic's EV-to-EBITDA falls into.
Hologic EV-to-EBITDA Calculation
Hologic's EV-to-EBITDA for today is calculated as:
Hologic's current Enterprise Value is $18,338 Mil.
Hologic's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,063 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (NAS:HOLX) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hologic's share price for today is $75.371.
Hologic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Hologic's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HOLX has been successfully added to your 